Chronic myeloid leukemia in a patient with previous idiopatic thrombocytopenic purpura how to manage imatinib together with eltrombopag

Medicine and Dentistry

• Idiopathic Thrombocytopenic Purpura 100%
• Chronic Myelogenous Leukemia 100%
• Imatinib 80%
• Eltrombopag 80%
• Therapeutic Procedure 60%
• Follow up 20%
• Platelet 20%
• Spontaneous Remission 20%
• Development 20%
• Myeloproliferative Disorder 20%
• Drug 20%
• Standing 20%
• Chemotherapeutic Agent 20%
• Thrombocytopenic Purpura 20%
• Association 20%
• Patient 20%
• Man 20%
• Laboratory 20%
• Janus Kinase 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Idiopathic Thrombocytopenic Purpura 100%
• Chronic Myeloid Leukemia 100%
• Imatinib 80%
• Eltrombopag 80%
• Case Report 40%
• Remission 20%
• Myeloproliferative Disorder 20%
• Drug 20%
• Thrombocytopenic Purpura 20%